| 1. |
- Li, Yongxi, et al.
(författare)
-
A fused-ring based electron acceptor for efficient non-fullerene polymer solar cells with small HOMO offset
- 2016
-
Ingår i: NANO ENERGY. - : ELSEVIER SCIENCE BV. - 2211-2855. ; 27, s. 430-438
-
Tidskriftsartikel (refereegranskat)abstract
- A non-fullerene electron acceptor bearing a novel backbone with fused 10-heterocyclic ring (in-dacenodithiopheno-indacenodiselenophene), denoted by IDTIDSe-IC is developed for fullerene free polymer solar cells. IDTIDSe-IC exhibits a low band gap (E-g=1.52 eV) and strong absorption in the 600850 nm region. Combining with a large band gap polymer J51 (E-g=1.91 eV) as donor, broad absorption coverage from 300 nm to 800 nm is obtained due to complementary absorption of J51 and IDTIDSe-IC, which enables a high PCE of 8.02% with a V-oc of 0.91 V, a J(SC) of 15.16 mA/cm(2) and a FF of 58.0% in the corresponding PSCs. Moreover, the EQE of 50-65% is achieved in the absorption range of IDTIDSe-IC with only about 0.1 eV HOMO difference between J51 and IDTIDSe-IC. (C) 2016 Elsevier Ltd. All rights reserved.
|
|
| 2. |
- Li, Yongxi, et al.
(författare)
-
Non-fullerene acceptor with low energy loss and high external quantum efficiency: towards high performance polymer solar cells
- 2016
-
Ingår i: Journal of Materials Chemistry A. - : Royal Society of Chemistry. - 2050-7488 .- 2050-7496. ; 4:16, s. 5890-5897
-
Tidskriftsartikel (refereegranskat)abstract
- A non-fullerene electron acceptor bearing a fused 10-heterocyclic ring (indacenodithiophenoindacenodithiophene) with a narrow band gap (similar to 1.5 eV) was designed and synthesized. It possesses excellent planarity and enhanced effective conjugation length compared to previously reported fused-ring electron acceptors. When this acceptor was paired with PTB7-Th and applied in polymer solar cells, a power conversion efficiency of 6.5% was achieved with a high open circuit voltage of 0.94 V. More significantly, an energy loss as low as 0.59 eV and an external quantum efficiency as high as 63% were obtained simultaneously.
|
|
| 3. |
|
|
| 4. |
- Chen, Xiaoping, et al.
(författare)
-
Risk factors for the delayed viral clearance in COVID‐19 patients
- 2021
-
Ingår i: The Journal of Clinical Hypertension. - : John Wiley & Sons. - 1524-6175 .- 1751-7176. ; 23:8, s. 1483-1489
-
Tidskriftsartikel (refereegranskat)abstract
- Comorbidities are important for the disease outcome of COVID-19, however, which underlying diseases that contribute the most to aggravate the conditions of COVID-19 patients are still unclear. Viral clearance is the most important laboratory test for defining the recovery of COVID-19 infections. To better understand which underlying diseases that are risk factors for delaying the viral clearance, we retrospectively analyzed 161 COVID-19 clinical cases in the Zhongnan Hospital of Wuhan University, Wuhan, China between January 5 and March 13, 2020. The demographic, clinical and laboratory data, as well as patient treatment records were collected. Univariable and multivariable analysis were performed to explore the association between delayed viral clearance and other factors by using logistic regression. Survival analyses by Kaplan-Meier and Cox regression modeling were employed to identify factors negatively influencing the viral clearance negatively. We found that hypertension and intravenous immunoglobulin adversely affected the time of viral RNA shedding. Hypertension was the most important risk factor to delay the SARS-CoV-2 virus clearance, however, the use of Angiotensin-Converting Enzyme Inhibitors(ACEI)/Angiotensin Receptor Blockers(ARB) did not shorten the time for virus clearance in these hypertensive patients’ virus clearance. We conclude that patients having hypertension and intravenous immunoglobulin may delay the viral clearance in COVID-19 patients.
|
|
